Home >

TAG Health Presents: A Conversation with Duke Margolis - Real World Data - Opportunities and Challenges


Date: June 14, 2019

Time: 11:30AM-1:00PM

Roam Perimeter Center 
1151 Hammond Drive NE, Suite 240 (2nd floor) 
Atlanta, GA 30346

The 21st Century Cures Act now allows the Federal Drug Administration to approve medical trials based on real world evidence and real world data.  The potential for many new life saving drugs and devices to reach the market quickly is exciting, but this blue ocean frontier still needs policy to guide safety and efficacy standards, leading many to ask how and when to leverage real world evidence/real world data (RWE/RWD).

Duke University’s Margolis Center for Health Policy is leading the conversation with researchers, policy makers, and industry to shape the way that real world data can be used.  Dr. Gregory Daniel, Duke Marolis’s Deputy Director will key note this event, sharing his expertise and insight on the key opportunities and challenges that Duke Margolis sees in its policy work.

A panel discussion with healthcare industry leaders who are driving the RWD discussion will follow.  In addition to Dr. Daniel, panelists include Dan O’Connor, Chief Strategy Officer at CioxHealth, Davind Maharaj, VP of Hosting & Client Technology at AllScripts. 

Lunch will be provided.

Keynote Speaker

Duke Margolis - Gregory W. Daniel, PhD, MPH, RPh - Deputy Director and Clinical Professor, Fuqua School of Business 

Gregory W. Daniel, PhD, MPH, RPh, directs the Duke-Margolis office in Washington, D.C. He leads the Center's pharmaceutical and medical device policy portfolio, which includes policy and data strategies for improving development and access to innovative pharmaceutical and medical device technologies. His expertise spans post-market evidence development to support increased value, improving regulatory science and drug development tools, optimizing biomedical innovation, and supporting drug and device payment reform.

Dr. Daniel is also a Senior Advisor to the Reagan-Udall Foundation for the FDA and Adjunct Associate Professor in the Division of Pharmaceutical Outcomes and Policy at the UNC Eshelman School of Pharmacy. Previously, he was Managing Director for Evidence Development & Biomedical Innovation in the Center for Health Policy and Fellow in Economic Studies at the Brookings Institution and Vice President, Government and Academic Research at HealthCore (subsidiary of Anthem, Inc).  Dr. Daniel’s research expertise includes utilizing electronic health data in designing research in health outcomes and pharmacoeconomics, comparative effectiveness, and drug safety and pharmacoepidemiology.


Julie Krommenhoek
Vice President, Life Sciences
Ciox Health

Dan O’Connor
Chief Strategy Officer

Davind Maharaj
VP of Hosting & Client Technology

Tim Eggena
Chief Strategy Officer

Registration for this event is closed.

My Registrations

No registrations found.
Association Management Software by MemberSuite
   Core Version:
Find us on Google+ Nebo Content Management System Tracking